Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM

Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes

(2016) Kimber M. Simmons et al.   Current Diabetes Reports

Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes

(2016) Michael R. Rickels et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Too Much or Too Little? The Double Jeopardy of Subcutaneous Insulin Therapy in Diabetes: Figure 1

(2015) Mark L. Evans   DIABETES

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

(2015) T. R. Pieber et al.   DIABETES OBESITY & METABOLISM

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

(2015) Mark R. Rigby et al.   JOURNAL OF CLINICAL INVESTIGATION

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

(2014) D. M. Nathan et al.   DIABETES

Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes

(2014) Michael R. Rickels et al.   DIABETES

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

(2014) Nicolai J. Wewer Albrechtsen et al.   DIABETOLOGIA

Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes

(2013) J. Sherr et al.   DIABETES CARE

Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia

(2013) Caroline K. Kramer et al.   DIABETES CARE

B-Lymphocyte Depletion With Rituximab and  -Cell Function: Two-Year Results

(2013) M. D. Pescovitz et al.   DIABETES CARE

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus

(2013) Ana Maria Arbelaez et al.   PEDIATRIC DIABETES

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes

(2012) A. Siafarikas et al.   DIABETES CARE

Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency

(2011) L. S. Farhy et al.   DIABETES OBESITY & METABOLISM

Physiologic action of glucagon on liver glucose metabolism

(2011) C. J. Ramnanan et al.   DIABETES OBESITY & METABOLISM

Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes

(2011) Philip E. Cryer   ENDOCRINOLOGY

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

(2011) Tihamer Orban et al.   LANCET

Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes

(2010) Kristine J. Hare et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Hypoglycemia in Type 1 Diabetes Mellitus

(2010) Philip E. Cryer   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Counterregulatory Responses to Hypoglycemia in Individuals With Type 1 Diabetes

(2008) V. J. Briscoe et al.   DIABETES